Ahluwalia Contracts. Cautious optimism BUY RESULTS REVIEW 4QFY17 31 MAY Highlights of the quarter

Similar documents
J. Kumar Infraprojects

Jubilant FoodWorks NEUTRAL RESULTS REVIEW 4QFY17 30 MAY Highlights of the quarter

Healty cigarette-driven growth

BLS International Services

Jubilant FoodWorks BUY RESULTS REVIEW 1QFY18 18 JULY Highlights of the quarter

Crompton Greaves Consumer Electricals

Crompton Greaves Consumer Electricals

Intellect Design Arena

Multi Commodity Exchange

Near-term pressure, but long-term outlook positive

BHEL SELL RESULTS REVIEW 1QFY15 13 AUG CMP (as on 12 Aug 2014) Rs 224 Target Price Rs 188

Discounting $45/bbl of realisation

Marico Kaya BUY RESULTS REVIEW 4QFY15 29 APR 2015

J. Kumar Infraprojects

Central Depository Services

Central Depository Services

PSP Projects. Marginal miss BUY RESULTS REVIEW 1QFY19 10 AUG 2018

NRB Bearings. Strong Show BUY RESULTS REVIEW 4QFY18 23 MAY Highlights of the quarter

Neuland Labs BUY RESULTS REVIEW 1QFY19 12 AUG 2018

Dilip Buildcon. Strong comeback BUY RESULT REVIEW 1QFY19 16 AUG Highlights of the quarter. CMP (as on 16 Aug 2018) Rs 847 Target Price Rs 1,434

Navin Fluorine International

PI Industries BUY RESULTS REVIEW 1QFY19 07 AUG Highlights of the quarter

Central Depository Services

Gulf Oil Lubricants BUY RESULTS REVIEW 1QFY19 09 AUG Key highlights

Pre-sales pickup key trigger

Capital Goods. 3QFY18E Results Preview. 10 Jan Sujit Jain

Construction. 4QFY18E Results Preview 14 APR Parikshit D Kandpal

Agrochemicals. 3QFY18E Results Preview 09 JAN Basanth Patil

Maruti Suzuki. A Trough Quarter BUY RESULTS REVIEW 3QFY19 25 JAN CMP(as on 25 Jan 2019) Rs 6,516 Target Price Rs 7,400

Hindustan Petroleum Corporation

Vinati Organics BUY RESULTS REVIEW 2QFY19 29 OCT INDUSTRY CHEMICALS CMP (as on 29 Oct 2018) Rs 1,408 Target Price Rs 1,700

Kalpataru Power Transmission

Real Estate. 3QFY19E Results Preview. 11 Jan Parikshit D Kandpal, CFA

Torrent Pharma BUY RESULTS REVIEW 1QFY18 01 AUG 2017

Hindustan Unilever BUY RESULTS REVIEW 4QFY17 18 MAY 2017

Mahanagar Gas BUY RESULTS REVIEW 1QFY19 01 AUG Highlights of the quarter. CMP (as on 1 Aug 2018) Rs 947 Target Price Rs 1,292

Brigade Enterprises. Stable performance BUY RESULTS REVIEW 2QFY19 14 NOV 2018

Hindustan Petroleum Corporation

Sun Pharma BUY RESULTS REVIEW 1QFY19 16 AUG 2018

Strong volumes, offset by costs

Alkem Labs BUY RESULTS REVIEW 1QFY19 11 AUG story remains on-track. Maintain BUY with a revised TP of Rs 2,410 (24x FY20E EPS).

Tata Steel. JV comes to fruition BUY COMPANY UPDATE 21 SEP Other key highlights. CMP (as on 20 Sep 17) Rs 688 Target Price Rs 818

Carborundum Universal

ICICI Prudential Life

Ambuja Cement. Realisations-driven beat SELL RESULTS REVIEW 2QCY17 25 JUL Highlights of the quarter

Geared for version 3.0

Real Estate. 4QFY17E Results Preview. 13 Apr Parikshit D Kandpal

Music Broadcast. In-line but muted BUY RESULTS REVIEW 2QFY19 26 OCT Key highlights. CMP (as on 26 Oct 2018) Rs 328 Target Price Rs 387

Agriculture. 4QFY18E Results Preview 13 APR Madhukar Ladha

Alkem Labs BUY RESULTS REVIEW 3QFY19 09 FEB CMP (as on 08 Feb 2019) Rs 1,904 Target Price Rs 2,340. Highlights of the quarter

Max Financial. Improving margins! BUY RESULTS REVIEW 4QFY18 30 MAY Highlights of the quarter

Suprajit Engineering. Synergies to accrue BUY COMPANY UPDATE 16 SEP 2016

Bajaj Auto BUY RESULTS REVIEW 1QFY18 21 JUL Highlights of the quarter

Weak quarter but well placed

Exide Industries BUY RESULTS REVIEW 4QFY18 08 MAY Highlights of the quarter. CMP (as on 08 May 2018) Rs 268 Target Price Rs 298

ITD Cementation (India) Ltd.

Navin Fluorine International

Jubilant Life Sciences

Hero MotoCorp BUY RESULTS REVIEW 2QFY19 16 OCT CMP (as on 16 Oct 2018) Rs 2,898 Target Price Rs 3,602. Highlights of the quarter

Brigade Enterprises BUY RESULTS REVIEW 2QFY16 03 NOV Highlights of the quarter. CMP (as on 03 Nov 2015) Rs 162 Target Price Rs 210

Reliance Industries. Timing is everything BUY COMPANY UPDATE 1 OCT 2014

Crompton Greaves Consumer Electricals

Cyient. Good show, priced in NEUTRAL RESULTS REVIEW 4QFY17 21 APRIL Highlights of the quarter

Coromandel International

Subros BUY RESULTS REVIEW 2QFY19 30 OCT CMP (as on 29 Oct 2018) Rs 268 TP Rs 435. Key highlights

Sonata Software. On growth path BUY RESULTS REVIEW 1QFY18 16 AUG Highlights of the quarter

Weak numbers in peak quarter

Bharti Infratel BUY RESULT REVIEW 3QFY19 25 JAN 2019

Ambuja Cement. Weak numbers SELL RESULTS REVIEW 1QCY17 01 MAY 2017

Dishman Carbogen Amcis

IRB Infrastructure Developers

Outperformance continues

Bharat Petroleum Corporation

Insecticides India BUY RESULTS REVIEW 4QFY17 30 MAY 2017

NIIT Technologies. NEUTRAL Higher capex weighing on FCF RESULTS REVIEW 2QFY15 16 OCT 2014

Bajaj Auto NEUTRAL RESULTS REVIEW 2QFY16 23 OCT Key highlights. CMP (as on 23 Oct 2015) Rs 2,514 Target Price Rs 2,720

JBM Auto. Ready to take off BUY RESULTS REVIEW 1QFY19 07 AUG Key highlights

Radico Khaitan BUY RESULTS REVIEW 3QFY19 24 JAN 2019

Construction & Infra. 1QFY19E Results Preview 10 JUL Parikshit D Kandpal

Residential recovery awaited

Emami NEUTRAL RESULTS REVIEW 4QFY15 14 MAY 2015

Dr. Reddy s Labs. Misery continues SELL RESULTS REVIEW 1QFY18 28 JUL 2017

Multi Commodity Exchange

Mphasis. Growth drivers intact BUY RESULTS REVIEW 3QFY19 25 JAN 2019

Thangamayil BUY RESULTS REVIEW 2QFY19 15 NOV 2018

ITC BUY RESULTS REVIEW 1QFY19 27 JUL 2018

Hexaware Technologies

Bharat Forge. Cyclical headwinds persist but structural story intact BUY COMPANY UPDATE 9 DEC Key takeaways

Lupin BUY COMPANY UPDATE 12 SEP 2013

Weak show, DCCDL key trigger

IRB Infrastructure Developers

V-Guard BUY RESULTS REVIEW 3QFY19 02 FEB 2019

Oil & Gas. 4QFY17E Results Preview. 13 Apr Deepak Kolhe

Growth + cash flows = BUY

Margin boost through non-core book

Mindtree. Steady quarter, Upside capped NEUTRAL RESULTS REVIEW 4QFY19 18 APR INDUSTRY CMP (as on 16 Apr 2019) Rs 972 Target Price Rs 1,040

Coal India. Tough times BUY COMPANY UPDATE 22 AUG CMP (as on 21 Aug 17) Rs 238 Target Price Rs 300

Chemicals and Fertilisers

Launch momentum picks up

FIRSTSOURCE SOLUTIONS LTD.

Transcription:

RESULTS REVIEW 4QFY17 31 MAY 2017 Ahluwalia Contracts BUY INDUSTRY INFRASTRUCTURE CMP (as on 31 May 2017) Rs 350 Target Price Rs 393 Nifty 9,621 Sensex 31,146 KEY STOCK DATA Bloomberg AHLU IN No. of Shares (mn) 67 MCap (Rs bn) / ($ mn) 23/363 6m avg traded value (Rs mn) 23 STOCK PERFORMANCE (%) 52 Week high / low Rs 410/235 3M 6M 12M Absolute (%) 9.9 42.3 28.2 Relative (%) 1.5 25.4 11.5 SHAREHOLDING PATTERN (%) Promoters 59.56 FIs & Local MFs 14.56 FPIs 19.45 Public & Others 6.43 Source : BSE Parikshit D Kandpal parikshitd.kandpal@hdfcsec.com +91-22-6171-7317 Cautious optimism AHLU s standalone 4QFY17 revenue/ebidta/apat grew 23/(19.3)/(23.8)% respectively. EBIDTA margin contracted 478bps YoY to 9.1% (8-quarter low). This was on account of 939bps expansion in other exp. AHLU has taken Rs 45mn of provisions for lease rental straight lining (non-cash) pertaining to KOTA BOT project. Besides the company had to incur elevated labour /subtracting charges post-demonet to meet the execution schedule. B/S is healthy, with standalone gross debt at Rs 890mn (net cash at Rs 310mn). AHLU expects to retire entire debt by FY19E. Order intake for FY17 stood at Rs 14bn, and AHLU has guided Rs 15bn inflow for FY18E as competitive intensity remains high. Order backlog stands at Rs 35.5bn. AHLU expects 12-15% revenue /EBIDTA growth respectively during FY18E. We rate AHLU as BUY with an SOTP of Rs 393/sh (Standalone EPC segment at 18x Mar-19E EPS, Kota BOT 1x P/BV). Highlights of the quarter Challenging quarter, pain not to last long: AHLU s 4QFY17 financial performance was impacted by Rs 45mn of provisioning for lease rental straight lining (non-cash) in other expenses for Kota BOT. Besides, company incurred higher labour/subtracting costs post demonetisation to meet the execution schedule. The pain is expected to remain during 1QFY18, as labour supply gets normalised and demonet impact wears off. Debt-free status by FY19E: AHLU has guided that the company will be debt-free by FY19E. This would be achieved through the use of cash flows from operation and promoters funds infusion (subject to approvals). AHLU will start paying dividend from FY19E. Near-term outlook: AHLU is going slow on new order bids, as it remains cautious on high competitive intensity in the building segment. The bid pipeline remains strong, and hence new order wins will lead to re-rating. We remain constructive on the stock. Financial Summary (Standalone) Y/E Mar (Rs mn) 4QFY17 4QFY16 YoY (%) 3QFY17 QoQ (%) FY16 FY17E FY18E FY19E Net Revenues 4,718 3,837 23.0 3,581 31.8 12,496 14,265 16,141 18,482 EBITDA 431 534 (19.3) 472 (8.8) 1,608 1,730 2,016 2,327 APAT 204 267 (23.8) 244 (16.8) 844 860 1,102 1,413 Diluted EPS (Rs) 1.4 1.9 (23.8) 1.7 (16.8) 12.6 12.8 16.5 21.1 P/E (x) 27.8 27.3 21.3 16.6 EV / EBITDA (x) 14.9 13.4 11.2 9.2 RoE (%) 22.2 18.5 19.6 20.5 HDFC securities Institutional Research is also available on Bloomberg HSLB <GO>& Thomson Reuters

AHLU s standalone 4QFY17 revenue/ebidta/apat grew 23/(19.3)/(23.8)% EBIDTA margins contracted by 478bps YoY to 9.1% (8 quarters low) This was on account of 939bps increase in other expenses. AHLU has taken Rs 45mn of provision for lease rental straight lining (non-cash) in other expenses. Besides labour/subtracting costs increased post demonetisation owing to shortage Weak EBIDTA margins may continue in 1QFY18E before improving in 2QFY18E as demonetisation effects wear off and labour supply improves Standalone Quarterly Financial Particulars (Rs mn) 4QFY17 4QFY16 YoY (%) 3QFY17 QoQ (%) FY17 FY16 YoY (%) Net Sales 4,718 3,837 23.0 3,581 31.8 14,265 12,496 14.2 Material Expenses (2,502) (2,061) 21.4 (1,888) 32.5 (7,262) (6,069) 19.7 Employee Expenses (332) (421) (21.1) (377) (11.9) (1,091) (935) 16.7 Other Operating Expenses (1,453) (822) 76.9 (843) 72.3 (4,181) (3,883) 7.7 EBITDA 431 534 (19.3) 472 (8.8) 1,730 1,608 7.6 Interest Cost (73) (120) (39.4) (60) 22.7 (267) (352) (24.0) Depreciation (67) (52) 27.4 (61) 9.0 (241) (201) 20.3 Other Income (Incl. EO Items) 21 45 (52.2) 12 78.6 84 136 (37.9) PBT 312 406 (23.0) 364 (14.1) 1,306 1,192 9.6 Tax (109) (138) (21.4) (119) (8.6) (446) (347) RPAT 204 267 (23.8) 244 (16.8) 860 844 1.9 Margin Analysis 4QFY17 4QFY16 YoY (bps) 3QFY17 QoQ (bps) FY17 FY16 YoY (bps) Material Expenses % Net Sales 53.0 53.7 (68) 52.7 30 50.9 48.6 234 Employee Expenses % Net Sales 7.0 11.0 (393) 10.5 (349) 7.6 7.5 16 Other Ope Expenses % Net Sales 30.8 21.4 939 23.6 725 29.3 31.1 (176) EBITDA Margin (%) 9.1 13.9 (478) 13.2 (406) 12.1 12.9 (74) Tax Rate (%) 34.8 34.1 70 32.7 209 34.1 29.2 499 APAT Margin (%) 4.3 7.0 (265) 6.8 (251) 6.0 6.8 (73) Kota project Rs 60mn/yr provisioning will continue FY17 order intake stands at Rs14bn and order backlog is Rs 35.5bn Page 2

We expect EBIDTA margins in the 12-13% range over FY17-19E Well-diversified order book segmentation Order book dominated by the government EBIDTA Margins To Remain In 12-13% Over FY17-19E 20,000 18,000 16,000 14,000 12,000 10,000 8,000 6,000 4,000 2,000 0 Revenues (Rs mn) FY11 FY12 FY13 FY14 FY15 EBIDTA Margins (%) - RHS FY16 FY17 FY18E FY19E 14.0 12.0 10.0 8.0 6.0 4.0 2.0 - (2.0) (4.0) Well Diversified Order Mix (%) Institutional 29 Infra 12 Hotels 1 Hospital 21 Residential (Pvt) 24 Residential (Gov) 8 Commercial 5 Only 3% of the order backlog is fixed price in nature Client Mix (%):Government Dominated Large Part Of Order Book Is With Escalation (%) Private 31 Fixed project 3 Govt 69 Variable project 97 Page 3

We expect muted growth in order backlog. Management cautious commentary on high competitive intensity in new bids is key reason for slow order intake FY17-19E revenue CAGR 13.8%, EBIDTA CAGR 16% Interest expense to reduce as AHLU deleverages balance sheet. High cash levels to result in higher other income FY17-19E RPAT CAGR of 28.2% AHLU to generate strong FCF Key Assumptions And Estimates STANDALONE FY17E FY18E FY19E Comments Closing order book 35,530 34,389 35,907 We expect muted order book CAGR as AHLU is cautiously approaching new bids owing to high competitive intensity Order book growth (%) (1.5) (3.2) 4.4 New order booking 13,722 15,000 20,000 In line with Rs 15-20bn/yr order intake guidance Book to bill ratio 2.5 2.1 1.9 Total Revenue 14,265 16,141 18,482 FY17-19E Revenue CAGR of 13.8% vs 12-15% guidance Growth (%) 14.2 13.2 14.5 EBIDTA 1,730 2,016 2,327 FY17-19E EBIDTA CAGR of 16% EBIDTA margin (%) 12.1 12.5 12.6 Margins to remain in 12-13% range Depreciation 241 260 261 Financial Charges 267 219 118 To reduce as AHLU expects to be debt free by FY19E PBT 1,306 1,645 2,109 FY17-19E PBT CAGR of 27.1% on back of deleveraging and higher other income PBT margin (%) 9.2 10.2 11.4 Tax 445.9 543.0 696.1 Tax rate (%) 34.1 33.0 33.0 RPAT 860 1,102 1,413 FY17-19E APAT CAGR of 28.2% Net margin (%) 6.0 6.8 7.6 Gross Block Turnover 4.2 4.0 4.0 To remain stable Debtor days 132 135 135 CFO - a 1,827 857 1,303 CFI - b (500) (234) (183) FCF - a+b 1,327 623 1,120 AHLU to generate strong FCF CFF - c (983) (220) (14) Total change in cash - a+b+c 343 403 1,106 Source: HDFC sec Inst Research Page 4

We value the standalone Building business at Rs 380/share (18x one-year forward Mar-19E EPS) Kota BOT at Rs 13/share (DCF Valuation, implied 0.96x P/BV of equity invested) Outlook and valuation TP of Rs 393/sh Valuation methodology We have valued AHLU s EPC business at 18x one-year forward earlier. Our rationale behind this is (1) Superior earnings quality vs peers, (2) Robust order backlog of Rs 35.5bn (2.5x FY17 revenue), (2) Near debt-free status by FY19E and (4) Limited BOT capex (Kota BOT equity of Rs 900mn already invested). Investments in the building segment would remain robust on the back of NBCC, CPWD and Private Capex in the segment. AHLU, with its strong execution skills, is likely to benefit from the pick-up in order activity. We rate AHLU as BUY with an SOTP-based target price of Rs 393/share. We value the (1) Standalone EPC business at Rs 380/share (18x one-year forward Mar-19E EPS), (2) Kota BOT at Rs 13/share (DCF valuation, implied 0.96x P/BV of equity invested). Our SOTP target price is Rs 393/share SOTP Valuation Particulars Segments Value Value per share (Rsmn) (Rs) Rationale AHLU Standalone Building business 25,438 380 At 18x Mar-19E EPS Kota BOT Project Lease rental 866 13 DCF Valuation, implied P/BV (x) 0.96x Total 26,304 393 Source: HDFC sec Inst Research Page 5

Income Statement (Standalone) Year ending March (Rs mn) FY15 FY16 FY17 FY18E FY19E Net Revenues 10,599 12,496 14,265 16,141 18,482 Growth (%) 10.4 17.9 14.2 13.2 14.5 Material Expenses 5,412 6,069 7,262 8,094 9,360 Employee Expenses 1,501 1,588 1,536 1,738 1,990 Other Operating Expenses 2,537 3,230 3,737 4,294 4,805 EBIDTA 1,149 1,608 1,730 2,016 2,327 EBIDTA (%) 10.8 12.9 12.1 12.5 12.6 EBIDTA Growth (%) 175.4 40.0 7.6 16.5 15.4 Depreciation 212 201 241 260 261 EBIT 937 1,408 1,489 1,756 2,066 Other Income (Incl. EO Items) 117 136 84 108 161 Interest 386 352 267 219 118 PBT 668 1,192 1,306 1,645 2,109 Tax 26 347 446 543 696 RPAT 641 844 860 1,102 1,413 APAT 641 844 860 1,102 1,413 APAT Growth (%) 194.9 31.6 1.9 28.2 28.2 EPS 9.6 12.6 12.8 16.5 21.1 EPS Growth (%) 176.3 31.6 1.9 28.2 28.2 Balance Sheet (Standalone) Year ending March (Rs mn) FY15 FY16 FY17E FY18E FY19E SOURCES OF FUNDS Share Capital 134 134 134 134 134 Reserves 3,243 4,087 4,947 6,049 7,462 Total Shareholders Funds 3,377 4,221 5,081 6,183 7,596 Minority Interest - - - - - Long Term Debt 90 1 - - - Short Term Debt 1,641 1,418 900 848 727 Total Debt 1,731 1,419 900 848 727 Deferred Taxes (153) (148) (134) (134) (134) Long Term Provisions & Others - - - - - TOTAL SOURCES OF FUNDS 4,955 5,493 5,847 6,897 8,190 APPLICATION OF FUNDS Net Block 1,948 1,965 1,925 1,966 2,005 CWIP 1 2 3 3 3 Goodwill - - - - - Investments, LT Loans & Advances 63 63 63 63 63 Total Non-current Assets 2,012 2,030 1,992 2,032 2,071 Inventories 1,665 2,047 2,008 2,432 2,785 Debtors 4,168 4,997 5,141 5,970 6,836 Cash & Equivalents 765 882 1,226 1,629 2,735 ST Loans & Advances, Others 1,661 1,464 1,857 1,935 2,017 Total Current Assets 8,259 9,391 10,231 11,966 14,373 Creditors 2,693 2,946 3,522 4,096 4,523 Other Current Liabilities & Provns 2,623 2,983 2,853 3,005 3,732 Total Current Liabilities 5,316 5,928 6,375 7,101 8,255 Net Current Assets 2,943 3,462 3,855 4,865 6,118 TOTAL APPLICATION OF FUNDS 4,955 5,493 5,847 6,897 8,190 Page 6

Cash Flow (Standalone) Year ending March (Rs mn) FY15 FY16 FY17E FY18E FY19E PBT 668 1,192 1,306 1,645 2,109 Non-operating & EO items (117) (136) (84) (108) (161) Interest expenses 386 352 267 219 118 Depreciation 212 201 241 260 261 Working Capital Change 17 (892) 528 (616) (328) Tax paid (17) (343) (432) (543) (696) OPERATING CASH FLOW ( a ) 1,149 373 1,827 857 1,303 Capex (176) (219) (203) (300) (300) Free cash flow (FCF) 973 154 1,624 557 1,003 Investments 13 267 (297) 66 118 INVESTING CASH FLOW ( b ) (163) 48 (500) (234) (183) Share capital Issuance 474 0 (0) - 0 Debt Issuance (655) (311) (520) (52) (121) Interest expenses (386) (352) (267) (219) (118) Dividend - - - - - Others (199) 360 (196) 51 225 FINANCING CASH FLOW ( c ) (766) (303) (983) (220) (14) NET CASH FLOW (a+b+c) 220 117 343 403 1,106 Opening cash balance 546 765 882 1,226 1,629 Closing Cash & Equivalents 766 882 1,226 1,629 2,735 Key Ratios (Standalone) FY15 FY16 FY17E FY18E FY19E PROFITABILITY (%) GPM 48.9 51.4 49.1 49.9 49.4 EBITDA Margin 10.8 12.9 12.1 12.5 12.6 EBIT Margin 8.8 11.3 10.4 10.9 11.2 APAT Margin 6.1 6.8 6.0 6.8 7.6 RoE 22.7 22.2 18.5 19.6 20.5 Core RoCE 21.8 21.9 21.5 22.6 25.7 RoCE 20.4 19.9 17.7 18.1 18.2 EFFICIENCY Tax Rate (%) 3.9 29.2 34.1 33.0 33.0 Asset Turnover (x) 2.2 2.3 2.5 2.4 2.3 Inventory (days) 57 60 51 55 55 Debtors (days) 144 146 132 135 135 Payables (days) 93 86 90 93 89 Cash Conversion Cycle (days) 108 120 93 97 101 Other Current Assets (days) 57 43 48 44 40 Other Current Liab (days) 90 87 73 68 74 Net Working Capital Cycle (Days) 75 75 67 73 67 Debt/EBITDA (x) 1.5 0.9 0.5 0.4 0.3 Net D/E 0.29 0.13 (0.06) (0.13) (0.3) Interest Coverage 2.4 4.0 5.6 8.0 17.5 PER SHARE DATA EPS (Rs/sh) 9.6 12.6 12.8 16.5 21.1 CEPS (Rs/sh) 12.7 15.6 16.4 20.3 25.0 DPS (Rs/sh) - - - - - BV (Rs/sh) 50 63 76 92 113 VALUATION P/E 36.6 27.8 27.3 21.3 16.6 P/BV 6.9 5.6 4.6 3.8 3.1 EV/EBITDA 21.3 14.9 13.4 11.2 9.2 OCF/EV (%) 4.7 1.6 7.9 3.8 6.1 FCF/EV (%) 4.0 0.6 7.0 2.5 4.7 FCFE/Market Cap (%) (0.3) (2.2) 3.6 1.2 3.3 Page 7

RECOMMENDATION HISTORY 450 Ahluwalia TP Date CMP Reco Target 31-May-17 350 BUY 393 400 350 300 250 200 May-16 Jun-16 Jul-16 Aug-16 Sep-16 Oct-16 Nov-16 Dec-16 Jan-17 Feb-17 Mar-17 Apr-17 May-17 Rating Definitions BUY : Where the stock is expected to deliver more than 10% returns over the next 12 month period NEUTRAL : Where the stock is expected to deliver (-)10% to 10% returns over the next 12 month period SELL : Where the stock is expected to deliver less than (-)10% returns over the next 12 month period Page 8

Disclosure: I, Parikshit Kandpal, MBA, author and the name subscribed to this report, hereby certify that all of the views expressed in this research report accurately reflect our views about the subject issuer(s) or securities. HSL has no material adverse disciplinary history as on the date of publication of this report. We also certify that no part of our compensation was, is, or will be directly or indirectly related to the specific recommendation(s) or view(s) in this report. Research Analyst or his/her relative or HDFC Securities Ltd. does not have any financial interest in the subject company. Also Research Analyst or his relative or HDFC Securities Ltd. or its Associate may have beneficial ownership of 1% or more in the subject company at the end of the month immediately preceding the date of publication of the Research Report. Further Research Analyst or his relative or HDFC Securities Ltd. or its associate does not have any material conflict of interest. Any holding in stock No HDFC Securities Limited (HSL) is a SEBI Registered Research Analyst having registration no. INH000002475. Disclaimer: This report has been prepared by HDFC Securities Ltd and is meant for sole use by the recipient and not for circulation. The information and opinions contained herein have been compiled or arrived at, based upon information obtained in good faith from sources believed to be reliable. Such information has not been independently verified and no guaranty, representation of warranty, express or implied, is made as to its accuracy, completeness or correctness. All such information and opinions are subject to change without notice. This document is for information purposes only. Descriptions of any company or companies or their securities mentioned herein are not intended to be complete and this document is not, and should not be construed as an offer or solicitation of an offer, to buy or sell any securities or other financial instruments. This report is not directed to, or intended for display, downloading, printing, reproducing or for distribution to or use by, any person or entity who is a citizen or resident or located in any locality, state, country or other jurisdiction where such distribution, publication, reproduction, availability or use would be contrary to law or regulation or what would subject HSL or its affiliates to any registration or licensing requirement within such jurisdiction. If this report is inadvertently send or has reached any individual in such country, especially, USA, the same may be ignored and brought to the attention of the sender. This document may not be reproduced, distributed or published for any purposes without prior written approval of HSL. Foreign currencies denominated securities, wherever mentioned, are subject to exchange rate fluctuations, which could have an adverse effect on their value or price, or the income derived from them. In addition, investors in securities such as ADRs, the values of which are influenced by foreign currencies effectively assume currency risk. It should not be considered to be taken as an offer to sell or a solicitation to buy any security. HSL may from time to time solicit from, or perform broking, or other services for, any company mentioned in this mail and/or its attachments. HSL and its affiliated company(ies), their directors and employees may; (a) from time to time, have a long or short position in, and buy or sell the securities of the company(ies) mentioned herein or (b) be engaged in any other transaction involving such securities and earn brokerage or other compensation or act as a market maker in the financial instruments of the company(ies) discussed herein or act as an advisor or lender/borrower to such company(ies) or may have any other potential conflict of interests with respect to any recommendation and other related information and opinions. HSL, its directors, analysts or employees do not take any responsibility, financial or otherwise, of the losses or the damages sustained due to the investments made or any action taken on basis of this report, including but not restricted to, fluctuation in the prices of shares and bonds, changes in the currency rates, diminution in the NAVs, reduction in the dividend or income, etc. HSL and other group companies, its directors, associates, employees may have various positions in any of the stocks, securities and financial instruments dealt in the report, or may make sell or purchase or other deals in these securities from time to time or may deal in other securities of the companies / organizations described in this report. HSL or its associates might have managed or co-managed public offering of securities for the subject company or might have been mandated by the subject company for any other assignment in the past twelve months. HSL or its associates might have received any compensation from the companies mentioned in the report during the period preceding twelve months from t date of this report for services in respect of managing or co-managing public offerings, corporate finance, investment banking or merchant banking, brokerage services or other advisory service in a merger or specific transaction in the normal course of business. HSL or its analysts did not receive any compensation or other benefits from the companies mentioned in the report or third party in connection with preparation of the research report. Accordingly, neither HSL nor Research Analysts have any material conflict of interest at the time of publication of this report. Compensation of our Research Analysts is not based on any specific merchant banking, investment banking or brokerage service transactions. HSL may have issued other reports that are inconsistent with and reach different conclusion from the information presented in this report. Research entity has not been engaged in market making activity for the subject company. Research analyst has not served as an officer, director or employee of the subject company. We have not received any compensation/benefits from the subject company or third party in connection with the Research Report. HDFC securities Limited, I Think Techno Campus, Building - B, "Alpha", Office Floor 8, Near Kanjurmarg Station, Opp. Crompton Greaves, Kanjurmarg (East), Mumbai 400 042 Phone: (022) 3075 3400 Fax: (022) 2496 5066 Compliance Officer: Binkle R. Oza Email: complianceofficer@hdfcsec.com Phone: (022) 3045 3600 HDFC Securities Limited, SEBI Reg. No.: NSE-INB/F/E 231109431, BSE-INB/F 011109437, AMFI Reg. No. ARN: 13549, PFRDA Reg. No. POP: 04102015, IRDA Corporate Agent License No.: HDF 2806925/HDF C000222657, SEBI Research Analyst Reg. No.: INH000002475, CIN - U67120MH2000PLC152193 Mutual Funds Investments are subject to market risk. Please read the offer and scheme related documents carefully before investing. Page 9

HDFC securities Institutional Equities Unit No. 1602, 16th Floor, Tower A, Peninsula Business Park, Senapati Bapat Marg, Lower Parel,Mumbai - 400 013 Board : +91-22-6171 7330 www.hdfcsec.com Page 10